These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 26507065)
1. [Erythema after subcutaneous heparin treatment]. Brouns AJ; Jie KS Ned Tijdschr Geneeskd; 2015; 159():A9304. PubMed ID: 26507065 [TBL] [Abstract][Full Text] [Related]
2. Timely diagnosis and management of heparin-induced thrombocytopenia in a frequent request, low incidence single centre using clinical 4T's score and particle gel immunoassay. Bryant A; Low J; Austin S; Joseph JE Br J Haematol; 2008 Dec; 143(5):721-6. PubMed ID: 19036016 [TBL] [Abstract][Full Text] [Related]
3. Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT)--findings from the GerHIT multi-centre registry study. Schindewolf M; Steindl J; Beyer-Westendorf J; Schellong S; Dohmen PM; Brachmann J; Madlener K; Pötzsch B; Klamroth R; Hankowitz J; Banik N; Eberle S; Kropff S; Müller MM; Lindhoff-Last E Thromb Res; 2014 Jul; 134(1):29-35. PubMed ID: 24703295 [TBL] [Abstract][Full Text] [Related]
4. Fondaparinux as a safe alternative for managing heparin-induced thrombocytopenia in postoperative cardiac surgery patients. Cegarra-Sanmartín V; González-Rodríguez R; Paniagua-Iglesias P; Santamaría-Ortiz A; Cueva LF; Galán-Serrano J; Moral-García MV J Cardiothorac Vasc Anesth; 2014 Aug; 28(4):1008-12. PubMed ID: 24439171 [TBL] [Abstract][Full Text] [Related]
5. Interrater agreement for two systems used to determine the probability of heparin-induced thrombocytopenia. Doré M; Frenette AJ; Chagnon I; Routhier N; Williamson D Am J Health Syst Pharm; 2014 Dec; 71(23):2045-52. PubMed ID: 25404596 [TBL] [Abstract][Full Text] [Related]
6. Fondaparinux for the treatment of acute heparin-induced thrombocytopenia: a single-center experience. Grouzi E; Kyriakou E; Panagou I; Spiliotopoulou I Clin Appl Thromb Hemost; 2010 Dec; 16(6):663-7. PubMed ID: 19825921 [TBL] [Abstract][Full Text] [Related]
7. The incidence of heparin-induced thrombocytopenia in patients treated with low molecular weight heparin for superficial vein thrombosis. Sartori M; Favaretto E; Migliaccio L; Guazzaloca G; Legnani C; Palareti G; Cosmi B Thromb Res; 2016 Mar; 139():154-7. PubMed ID: 26916314 [TBL] [Abstract][Full Text] [Related]
12. Treatment of heparin-induced thrombocytopenia with fondaparinux. Harenberg J; Jörg I; Fenyvesi T Haematologica; 2004 Aug; 89(8):1017-8. PubMed ID: 15339691 [TBL] [Abstract][Full Text] [Related]
13. Egyptian experience of reliability of 4T's score in diagnosis of heparin induced thrombocytopenia syndrome. Tawfik NM; Hegazy MA; Hassan EA; Ramadan YK; Nasr AS Blood Coagul Fibrinolysis; 2011 Dec; 22(8):701-5. PubMed ID: 22008905 [TBL] [Abstract][Full Text] [Related]
14. [Fondaparinux treatment in heparin induced thrombocytopenia:a case report]. Ozsu S; Korkmaz A; Bülbül Y; Oztuna F; Ozlü T Tuberk Toraks; 2011; 59(2):178-83. PubMed ID: 21740395 [TBL] [Abstract][Full Text] [Related]
15. [Arterial thrombosis due to heparin induced thrombocytopenia]. Klinkert LC; van Leeuwen DG; Brouwers AJ; van der Klooster JM Ned Tijdschr Geneeskd; 2013; 157(39):A6237. PubMed ID: 24063671 [TBL] [Abstract][Full Text] [Related]